Acorafloxacin is a broad-spectrum fluoroquinolone antibacterial drug being developed for the treatment of acute bacterial skin and skin structure infections and community-acquired pneumonia.

1001162-01-1

C21H24ClF2N3O4

455.88

Acorafloxacin hydrochloride;JNJ-Q2 hydrochloride;JNJ-Q2 HCl;JNJ 32729463;JNJ-32729463;Acorafloxacin HCl

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years